498 related articles for article (PubMed ID: 35789479)
21. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
[TBL] [Abstract][Full Text] [Related]
22. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
23. Developing a core outcome set for interventions to improve discharge from mental health inpatient services: a survey, Delphi and consensus meeting with key stakeholder groups.
Tyler N; Wright N; Grundy A; Waring J
BMJ Open; 2020 May; 10(5):e034215. PubMed ID: 32404388
[TBL] [Abstract][Full Text] [Related]
24. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
25. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
26. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
Karnik NS; Campbell CI; Curtis ME; Fiellin DA; Ghitza U; Hefner K; Hser YI; McHugh RK; Murphy SM; McPherson SM; Moran L; Mooney LJ; Wu LT; Shmueli-Blumberg D; Shulman M; Schwartz RP; Stephens KA; Watkins KE; Marsden J
Trials; 2021 Jan; 22(1):102. PubMed ID: 33509278
[TBL] [Abstract][Full Text] [Related]
27. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
[TBL] [Abstract][Full Text] [Related]
28. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
29. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; Peiffer B; Ravaud P; Tran VT; Armand ML; Moryousef S; Ferkal S; Jannic A; Ezzedine K; Wolkenstein P;
Br J Dermatol; 2024 Jan; 190(2):216-225. PubMed ID: 37877514
[TBL] [Abstract][Full Text] [Related]
30. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
[TBL] [Abstract][Full Text] [Related]
31. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
32. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
[TBL] [Abstract][Full Text] [Related]
33. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.
Harman NL; Wilding JPH; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
BMJ Open Diabetes Res Care; 2019; 7(1):e000700. PubMed ID: 31908789
[TBL] [Abstract][Full Text] [Related]
34. Core Outcome Measures for Palliative and End-of-Life Research After Severe Stroke: Mixed-Method Delphi Study.
Mason B; Boyd K; Doubal F; Barber M; Brady M; Cowey E; Visvanathan A; Lewis S; Gallacher K; Morton S; Mead GE
Stroke; 2021 Nov; 52(11):3507-3513. PubMed ID: 34266306
[TBL] [Abstract][Full Text] [Related]
35. Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.
Millar AN; Daffu-O'Reilly A; Hughes CM; Alldred DP; Barton G; Bond CM; Desborough JA; Myint PK; Holland R; Poland FM; Wright D;
Trials; 2017 Apr; 18(1):175. PubMed ID: 28403876
[TBL] [Abstract][Full Text] [Related]
36. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey.
Evangelidis N; Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Sautenet B; O'Donoghue D; Tam-Tham H; Youssouf S; Mandayam S; Ju A; Hawley C; Pollock C; Harris DC; Johnson DW; Rifkin DE; Tentori F; Agar J; Polkinghorne KR; Gallagher M; Kerr PG; McDonald SP; Howard K; Howell M; Craig JC;
Am J Kidney Dis; 2017 Oct; 70(4):464-475. PubMed ID: 28238554
[TBL] [Abstract][Full Text] [Related]
37. Determine what to measure and how to measure in clinical trials for the treatment of pressure injury: A protocol for the development of a core outcome set.
Shi J; Gao Y; Si L; Ma X; Liu M; Liao X; Zhang J
Medicine (Baltimore); 2020 Feb; 99(9):e19311. PubMed ID: 32118756
[TBL] [Abstract][Full Text] [Related]
38. Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'.
Demidova A; Drewitz KP; Kimkool P; Banjanin N; Barzylovich V; Botjes E; Capper I; Castor MAR; Comberiati P; Cook EE; Costa J; Chu DK; Epstein MM; Galvin AD; Giovannini M; Girard F; Golding MA; Greenhawt M; Ierodiakonou D; Jones CJ; Khaleva E; Knibb RC; Macit-Çelebi MS; Mack DP; Mafra I; Marchisotto MJ; Mijakoski D; Nekliudov N; Özdemir C; Patel N; Pazukhina E; Protudjer JLP; Rodríguez Del Rio P; Roomet J; Sammut P; Schoos AM; Schopfer AF; Schultz F; Seylanova N; Skypala I; Sørensen M; Stoleski S; Stylianou E; Upton J; van de Veen W; Genuneit J; Boyle RJ; Apfelbacher C; Munblit D;
Allergy; 2024 Apr; 79(4):977-989. PubMed ID: 38433402
[TBL] [Abstract][Full Text] [Related]
39. coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials.
Tambor E; Robinson M; Hsu L; Chang HY; Al Naber J;
BMC Med Res Methodol; 2021 Oct; 21(1):219. PubMed ID: 34666680
[TBL] [Abstract][Full Text] [Related]
40. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
